Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
4.950
-0.140 (-2.75%)
At close: Nov 11, 2026, 4:00 PM EST
4.900
-0.050 (-1.01%)
After-hours: Nov 11, 2026, 4:27 PM EST

Clearmind Medicine Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
201012
Market Cap Growth
383.43%-22.85%216.83%-81.96%-55.59%-
Enterprise Value
-12-3-7-40-3
Last Close Price
5.09254.56444.801170.2475840.05170756.29

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
PB Ratio
0.110.370.180.18-0.890.57
P/TBV Ratio
0.180.400.190.21-0.60

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Debt / Equity Ratio
0.141.490.02--0.04-
Net Debt / Equity Ratio
-1.09-3.19-2.19-5.610.26-0.96
Net Debt / EBITDA Ratio
1.600.671.190.880.051.25
Net Debt / FCF Ratio
2.000.801.400.880.081.60
Quick Ratio
4.281.211.711.160.2213.33
Current Ratio
4.311.221.721.170.2313.78
Return on Equity (ROE)
-106.98%-179.39%-256.89%--570.96%-145.26%
Return on Assets (ROA)
-53.08%-53.11%-54.37%-116.22%-169.53%-83.90%
Return on Capital Employed (ROCE)
-67.90%-475.20%-183.90%-640.90%565.20%-76.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Earnings Yield
-2392.12%-887.10%-932.40%-4846.52%-699.33%-135.15%
FCF Yield
-313.95%-1088.92%-862.13%-3542.60%-378.33%-104.21%
SEC Filings: 10-K · 10-Q